02 Apr 2024

Cutting edge cancer research to help change the game for patients

Innovative new research projects targeting improved lung cancer outcomes have now been given the green light through joint Lung Foundation Australia and Cancer Australia funding.

02 Apr 2024

Public Consultation: Draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP

Consultation on the draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme (PBS) and designated vaccines on the National Immunisation Program (NIP) is now open.

02 Apr 2024

Opioid prescriptions are down – but is dependence?

While PBS listing revisions have potentially reduced opioid prescriptions, experts say more active treatment is required to reduce harm.

02 Apr 2024

Q fever vaccination added to the AIR

The immunisations, which can only be administered once in a person’s life, were previously tracked by a private meat processing company.

02 Apr 2024

Drug expanded on PBS for CKD treatment

GPs can now prescribe empagliflozin for eligible patients with chronic kidney disease, but should be aware of specific eligibility criteria.

02 Apr 2024

Report shows potential for targeted general practice investment

Last year’s incentive and indexation changes are stabilising plummeting bulk billing rates, new data has found, but more is needed to keep practices viable.

02 Apr 2024

New Supporting Recovery from Family, Domestic and Sexual Violence service has begun

Your patients who have experienced family, domestic or sexual violence can now seek help from a new SWSPHN-funded program which aims to provide victim-survivors with access to services to support their long-term recovery.

02 Apr 2024

SafeScript NSW: approval management enhancements now available

Prescribers are now able to submit applications in SafeScript NSW for approval to prescribe Schedule 8 Pain Management Medicines, Schedule 8 Benzodiazepines, and Esketamine and Ketamine when used to manage treatment-resistant depression.

02 Apr 2024

HealthPathways marks significant milestone

Congratulations to the South Western Sydney HealthPathways team who have reached the huge milestone of 700 clinical pathways being localised.

02 Apr 2024

Practice Nurse Profile – Melissa Gajardo

Melissa Gajardo’s passion for nursing led her to a career in primary care.